Aethlon Medical, Inc. - Common Stock, $0.001 par value per share (AEMD)
CUSIP: 00808Y406
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 768,300
- Total 13F shares
- 181,306
- Share change
- +129,336
- Total reported value
- $89,160
- Price per share
- $0.50
- Number of holders
- 18
- Value change
- +$63,245
- Number of buys
- 10
- Number of sells
- 2
Quarterly Holders Quick Answers
What is CUSIP 00808Y406?
CUSIP 00808Y406 identifies AEMD - Aethlon Medical, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00808Y406:
Top shareholders of AEMD - Aethlon Medical, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Sabrina Martucci Johnson |
3/4/5
|
Director |
—
class O/S missing
|
33,642
|
$73,676 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.8%
|
21,224
|
$35,656 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.6%
|
20,274
|
$34,060 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.96%
|
7,340
|
$12,331 | — | 31 Mar 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.16%
|
1,217
|
$2,045 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.15%
|
1,137
|
$1,910 | — | 31 Mar 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.04%
|
299
|
$501 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.03%
|
230
|
$386 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
134
|
$225 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
89
|
$150 | — | 31 Mar 2024 | |
| BARTLETT & CO. WEALTH MANAGEMENT LLC |
13F
|
Company |
0%
|
26
|
$44 | — | 31 Mar 2024 | |
| Charles J. Fisher Jr. |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
192,600
|
— | — | 10 Feb 2022 | |
| Guy F. Cipriani |
3/4/5
|
Sr. V.P., Chief Bus. Officer, Director |
—
class O/S missing
|
100,200
|
— | — | 10 Feb 2022 | |
| James B. Frakes |
3/4/5
|
CFO & Sr. VP ? Finance |
—
class O/S missing
|
100,200
|
— | — | 10 Feb 2022 | |
| Steven P. Larosa |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
100,200
|
— | — | 10 Feb 2022 | |
| Lee D. Arnold |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
60,620
|
— | — | 01 Feb 2023 |
Institutional Holders of Aethlon Medical, Inc. - Common Stock, $0.001 par value per share (AEMD) as of Q2 2024
As of 30 Jun 2024,
Aethlon Medical, Inc. - Common Stock, $0.001 par value per share (AEMD) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
181,306 shares.
The largest 10 holders included
SUSQUEHANNA INTERNATIONAL GROUP, LLP, TWO SIGMA SECURITIES, LLC, JANE STREET GROUP, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Baader Bank Aktiengesellschaft, HRT FINANCIAL LP, BlackRock Inc., Tower Research Capital LLC (TRC), and UBS Group AG.
This page lists
18
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
10
Q2 2024 holders
18
Holder diff
8
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.